Ultragenyx Pharmaceutical reported $135.93M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 88.22M 7.11M
Acceleron Pharma XLRN:US $ 57.37M 2.11M
Agios Pharmaceuticals AGIO:US $ 57.9M 2.75M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
Alnylam Pharmaceuticals ALNY:US $ 610.66M 56.01M
Aptinyx Inc APTX:US $ 6.28M 2.9M
Biomarin Pharmaceutical BMRN:US $ 514.9M 71.55M
Bluebird Bio BLUE:US $ 266.56M 18.79M
Epizyme EPZM:US $ 44.74M 3.84M
Esperion Therapeutics ESPR:US $ 78.48M 4.16M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Insmed INSM:US $ 112.5M 12.84M
IONIS PHARMACEUT IONS:US $ 218M 75.82M
Karyopharm Therapeutics KPTI:US $ 68.87M 10.74M
Kyowa Hakko Kirin 4151:JP Y 87709M 12290M
Macrogenics MGNX:US $ 68.86M 1.06M
Mirati Therapeutics MRTX:US $ 122.08M 58.79M
Moderna Inc MRNA:US 9.96B 1.12B
Neurocrine Biosciences NBIX:US $ 225.9M 13M
Ptc Therapeutics PTCT:US $ 465.26M 174.3M
Puma Biotechnology PBYI:US $ 116.26M 21.64M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M
Sarepta Therapeutics SRPT:US $ 373.44M 51.58M
Ultragenyx Pharmaceutical RARE:US $ 135.93M 8.87M
Vertex Pharmaceuticals VRTX:US $ 1914.26M 77.82M
Vital Therapies VTL:US $ 10.59M 3.9M
Xoma XOMA:US $ 6.51M 221K